MADISON BLANKENSHIP: Open Payments
NPI 1073281242 · GLENWOOD, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 11 payments from 5 companies in 2025. Trend: 2023 $244 · 2024 $205 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $90 |
| PFIZER INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Amgen Inc. | 1 | $15 |
Products named: MOUNJARO, ELIQUIS, XIFAXAN, EVENITY, VYNDAMAX.
Industry payments across IA — which companies pay providers there.
